Neonatal Hypoglycaemia: The AAP Screening Algorithm Explained
Who to screen, when to feed and when to give IV glucose: the AAP’s practical approach to low glucose in late-preterm and term newborns.
Who to screen, when to feed and when to give IV glucose: the AAP’s practical approach to low glucose in late-preterm and term newborns.
A 90-minute-old, asymptomatic baby reads 1.9 mmol/L — and three clinicians cite three different guidelines, all correct. This deep-dive unpacks why neonatal hypoglycaemia has no single validated number, who to screen, how to treat progressively, and why the thresholds diverge. Treat the baby, not the number.
Karyotype, microarray, panel, exome or genome — each genetic test looks at a different scale and each has a blind spot. In this discussion, our experts break down what every test actually sees, where it falls short, and how to choose the right one for a sick newborn.
A baby is born dysmorphic and the team asks: does this need a genetic test, and which one? Here is the diagnostic pathway from cot-side assessment to genome sequencing — and how to choose well.